Drug "Neoton": okwu

Drug "Neoton" - a ọgwụ na-eji na ọgwụgwọ nke ala ala obi ọdịda, ọrụ, myocardial infarction (nnukwu), cerebrovascular ọrịa, N'ịdị ischemia na emee n'oge ịwa ahụ. Ihe bụ isi ụdị ntọhapụ nke ọgwụ bụ a lyophilized powder nke na-eji maka na-akwadebe ihe ngwọta maka nzube nke igba ogwu n'akwara infusion. Drug "Neoton" ke egwuregwu a na-eji dị ka ngwá ọrụ maka mgbochi nke ihe ịrịba ama nke ahụ nchegbu, mma usọ mmegharị oké ibu.

"Neoton" ọgwụ ọjọọ. Ntuziaka maka ojiji: mejupụtara, pharmacokinetics

The mejupụtara nke ọgwụ ugbu ifịk umi "creatine phosphate sodium nnu." Mgbe a otu infusion kacha ọdịnaya nke ọgwụ na systemic mgbasa a hụrụ mgbe atọ nkeji. The ọgwụ accumulates na myocardium, ụbụrụ, skeletal muscle. The ọkara ndụ bụ nkeji iri atọ. Nyere ọgwụ bụ isi ihe na akụrụ ya.

"Neoton" ntụ ntụ. Ntuziaka: pharmacodynamics

The agwọ ọrịa ịrịba mma muscle anụ ahụ metabolism infarction. Dị ka ihe owuwu, o yiri phosphocreatine, ya mere, bụ ike nke na inhibiting omume rụrụ arụ ndị Filiks sarkolemy ischemic obi mkpụrụ ndụ, na-enye ume-kpụ ọkụ n'ọnụ intracellular iga njikọ. The ọgwụ ike nke na mbenata mpaghara nke necrosis, ischemia site na ụba ka ọbara na ebe ndị a.

"Neoton" ọgwụ ọjọọ. Ntụziaka: The usoro nke ngwa, na onunu ogwu

Mgbe a n'ihu mmepe nke nnukwu myocardial infarction anọ grams ndinọ intravenously, mgbe ahụ, na-ebu infusion nke glucose ngwọta. Ekemende dose na-okpukpu abụọ. infusion ọnụego bụ ụbọchị isii. N'ihi na ọgwụgwọ nke ala ala gbasara obi insufficiency ọrụ zuru ezu na-ewebata abụọ grams nke nkwadebe kwa ụbọchị nke mbụ izu abụọ. Maka ọgwụgwọ nke myocardial ischemia n'oge na-emepe emepe ọrụ, ọgwụ mejupụtara na ẹkenam n'ime cardioplegic ngwọta ke ichekwa atọ grams kwa liter. Iji nweta ihe ọgwụgwọ mmetụta dị mkpa na-ebu abụọ infusions kwa ụbọchị ruo ụbọchị asaa. Iji gbochie postoperative ischemic N'ịdị abụọ anọ grams nke ọgwụ inye intravenously eji glucose ngwọta na-eme n'ọdịnihu.

"Neoton" ọgwụ ọjọọ. Ntuziaka: contraindications, ọgwụ interactions

Naanị contraindication na eji nke a nkwadebe bụ ọnụnọ nke hypersensitivity ya Efrata. The ojiji nke a ọgwụ na ọgwụgwọ mejupụtara enhances ihe nke mgbagwoju ọdịdị nke antianginal, antiarrhythmic, inotropic ọgwụ ọjọọ.

Drug "Neoton". Ntụziaka: pụrụ iche ntụziaka

Ọ dị mkpa iji zere ngwa nchịkwa ke doses na gafere otu gram phosphocreatine, ebe ọ pụrụ ime ka mberede ọbara mgbali fluctuations.

The ọgwụ ga-ndinọ ozugbo o kwere omume site na mmalite nke mbụ ihe ịrịba ama nke ischemia. Ọ ana achi achi mmepe nke kasị mma prognosis nke ọrịa. Unu na-eji "Neoton" n'ihi na mberede ọgwụgwọ nke gbasara obi ọrụ.

N'oge a, e nweghị ihe ọ data on nwere nchekwa, nrụpụta n'oge lactation, ime. The ọgwụ adịghị ike na-emetụta ndị dị ize ndụ ígwè management nkà, pụtara nke iga. The ọgwụ enweghị ike mmetụta.

The ọgwụ kwesịrị echekwara na okpomọkụ adịghị nnọọ + 30 Celsius C. The nkwadebe bụ kwesịrị ekwesị n'ihi na afọ atọ. Mgbe ọgwụgwụ nke oge a, ọ na-efunari niile bara uru pharmacological Njirimara, otú ị ga-akwụsị iji ya mgbe oge a.